To determine the prevalence of elevated C-reactive protein (CRP) in the Sandy Lake Oji-Cree, an aboriginal community residing in the Sioux Lookout zone of Northwestern Ontario, Canada, and to determine the associations of obesity and diabetes with CRP in a community with a very high prevalence of type II diabetes. DESIGN: We surveyed 512 community members aged 18 y and older to determine the prevalence and the determinants of elevated CRP in Sandy Lake. MEASUREMENTS: Clinical variables, indices of obesity and serum concentrations of CRP, insulin, serum amyloid A (SAA) and interleukin-6 (IL-6). RESULTS: The prevalence of CRP Z3.8 mg/l was significantly higher in women than in men (51% vs. 32%, Po0.0001). Regression analysis determined that body mass index and IL-6 were independent determinants of CRP concentration in women and waist circumference and IL-6 were independent determinants of CRP concentration in men. Diabetes was associated with elevated CRP in both sexes, but was only a moderate strong determinant in CRP concentration in multivariate regression analysis. CONCLUSIONS: The prevalence of elevated CRP in this aboriginal community is remarkably high. These data further demonstrate that the association between CRP and specific indices of obesity and metabolism vary according to gender and glycemic status.
Introduction
Recent prospective epidemiologic studies have identified serum C-reactive protein (CRP) as an independent predictor of coronary heart disease (CHD) in men and women. [1] [2] [3] [4] [5] CRP is an acute-phase reactant that is now known to be stably present at low levels in many individuals. [6] [7] [8] CRP is made by the liver, primarily in response to the cytokine interleukin-6 (IL-6). 9 Adipose tissue is an important source of IL-6, 9-11 and there is a strong positive association between body mass index (BMI) and both IL-6 11 and CRP. 12 An apparently inextricable mechanism underlying these associations is insulin resistance. IL-6 is increased in insulin-resistant states, and this might account for the higher serum CRP concentrations observed in diabetes. 13 Serum amyloid A (SAA) is another inflammatory protein that has been studied for a possible role in CHD and that has also been correlated with CRP. 14 In contrast, vitamin B 6 was recently found to be inversely correlated with CRP, possibly reflecting vitamin B 6 utilization in the presence of underlying inflammation. 15 North American aboriginal populations have undergone a seismic transformation of culture and lifestyle within the last half-century. As a result, these groups have acquired diseases that are typically associated with Westernization, sometimes expressing these diseases in large excess compared to other ethnic groups. [16] [17] [18] Certain North American aboriginal groups appear to be particularly susceptible to the development of obesity and type II diabetes, although serum CRP has not been extensively studied in these populations. The population prevalence of type II diabetes among the Oji-Cree of the Sandy Lake reserve in Northern Ontario is among the world's highest, with an age-adjusted prevalence of 26% for diabetes and 14% for impaired glucose tolerance. 16, 17 Furthermore, the CHD incidence in the region of Ontario containing the Sandy Lake reserve is several-fold higher than in the rest of the province. 18 We have found that normoglycemic subjects in the Sandy Lake cohort are younger and on average have desirable lipid levels, whereas hyperglycemic subjects are older and frequently have undesirable lipid levels and hypertension. 19 We thus examined concentrations of serum CRP in diabetic and nondiabetic Oji-Cree from the Sandy Lake reserve. We also examined SAA, IL-6 and vitamin B 6 concentrations in this study sample. We report here that elevated serum CRP concentration is found in the majority of Oji-Cree living on the Sandy Lake reserve. In addition, the prevalence of elevated serum CRP is significantly higher in women than in men. The major determinants of CRP are indices of obesity and IL-6, but the relation between diabetes status and CRP appears to be complex. This study shows that CHD risk in these aboriginal people is greater than previously thought. The signature of chronic inflammationFelevation of CRP, serum amyloid A and IL-6Filluminates a potential public health concern for this population.
Methods

Study subjects
The methodology of the Sandy Lake Health and Diabetes Prevalence project has previously been described. 16 Briefly, between July 1993 and December 1995, 728 of 1018 residents (72%) of Sandy Lake aged 10-79 y participated in a population-based cross-sectional survey to determine the prevalence of type II diabetes and its associated risk factors. Signed informed consent was obtained from all participants, and the study was approved by the Sandy Lake First Nation Band Council and the University of Toronto Ethics Review Board. The cross-sectional component of the current study is based on 512 individuals aged 18 y and older for whom specimens were available for full analysis. Participants provided fasting blood samples after an 8-12 h overnight fast. A 75 g oral glucose tolerance test (OGTT) was administered, and a second sample for glucose was drawn after 120 min. Individuals were excluded from the OGTT if they had physician-diagnosed diabetes and were (a) currently receiving treatment with insulin or oral hypoglycemic agents or (b) if they had a fasting blood glucose concentration exceeding 11.1 mmol/l. Women who were pregnant at the time of initial contact received their OGTT 3 months postpartum. Diabetes was defined as a fasting blood glucose greater than or equal to 7.8 mmol/l or an OGTT glucose greater than or equal to 11.1 mmol/l and impaired glucose tolerance (IGT) was defined as those subjects who did not have diabetes, but had an OGTT glucose greater than or equal to 7.8 mmol/l. 20 Blood chemistries Serum CRP concentration (between day CV 5.0% at 12.8 mg/ l) was determined using the Behring BN100 and the N highsensitivity C-reactive protein reagent (Dade-Behring, Mississauga, ON, Canada). 21 SAA (between day CV 11% at 81 mg/l) was measured using the Biosource ELISA (Human SAA Cytoscreen ELISA Immunoassay kit Catalog #KHA0012, BioSource International, Camarillo, CA, USA) and IL-6 (between day CV 10% at 2 ng/l) was measured using the Biosource ELISA (Human IL-6 US UltraSensitive Cytoscreen ELISA Immunoassay Kit Catalog #KHC0063, BioSource International, Camarillo, CA, USA). Vitamin B 6 (between day CV 10.5% at 20 nmol/l) was measured using the radioenzymatic assay from ALPCO (ALPCO Catalog #001-RK-VB6, ALPCO, Windham, NH, USA). All other measurements were done as previously described.
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Statistical analyses SAS version 8 was used for statistical analyses (SAS Institute, Cary NC, USA). The deviation from normality for each variable was determined using univariate analysis and the transformation was selected on the basis of analysis with the guided data analysis routine. Regression analysis was carried out by the forward selection method. A priori, a decision was made to analyze data separately for men and women, whenever sample size allowed. A posteriori, a decision was made to pool the subjects with newly diagnosed diabetes, IGT, and previously diagnosed diabetes because of the small numbers of subjects in the gender-specific subcategories.
Results
Baseline clinical and biochemical characteristics Table 1 shows the characteristics of the study sample classified by gender. The distributions of most variables, including CRP, were highly skewed and thus mean, median and s.d. are shown for each. The prevalence of obesity, classified as a BMIZ27, was 50% in men and 65% in women (P ¼ 0.0005). The prevalence of obesity, classified by a waist circumference Z100 cm for men and Z90 cm for women, was 49% in men and 85% in women (P ¼ 0.0001). The prevalence of diabetes and IGT was 23 and 18%, respectively, in women and 20 and 5%, respectively, in men (P-value for IGT ¼ 0.0001).
Univariate correlations of inflammatory markers with clinical and biochemical markers Spearman rank correlations were determined for women and men separately. As a result of variable numbers of subjects in the three affected classes (eg 52 women and 13 men with IGT), correlations were carried out for nondiabetic subjects and for affected subjects with either IGT or diabetes. Three measures of obesity were also analyzed: BMI, waist circumference and the ratio of waist-to-hip circumference (WHR). In addition, fasting blood insulin, fasting blood glucose (FBG) and 2 h postglucose challenge glucose (2 h PC) were analyzed.
In normal Oji-Cree women (Table 2) , CRP was strongly correlated with all three measures of obesity. CRP was also significantly correlated with insulin, FBG and 2 h PC. CRP was positively correlated with age, SAA and IL-6, and negatively correlated with vitamin B 6 . SAA was strongly correlated with obesity as measured by BMI and waist, but not WHR. SAA was positively correlated with insulin, FBG and 2 h PC and negatively correlated with vitamin B 6 . IL-6 was significantly correlated with BMI and waist, but only a trend to correlation with WHR was seen. IL-6 was correlated with insulin and 2 h PC, but not with FBG.
In normal Oji-Cree men (Table 2) , CRP was strongly correlated with all three measures of obesity (with WHR having a stronger correlation than in women). CRP was also significantly correlated with insulin, FBG and 2 h PC. As in women, CRP was positively correlated with age, SAA and IL-6, and negatively correlated with vitamin B 6 . The correlation of SAA with measures of obesity was statistically significant, but was weaker than that observed for CRP. Further, SAA was positively correlated with insulin, but not with FBG or 2 h PC. There was no correlation of SAA with age, but there was a negative correlation with vitamin B 6 . IL-6 was significantly correlated with measures of obesity, but not with insulin, FBG or 2 h PC. Further, IL-6 was not correlated with age, but was negatively correlated with vitamin B 6 .
Thus, among the normoglycemic subjects, we observed univariate correlations of the inflammatory factors CRP, SAA and IL-6 with indices of obesity and glycemia that differed by gender. In women, BMI and waist were better correlated with CRP, SAA and IL-6 than was WHR, whereas in men, each measure of obesity gave similar r-values with these variables. Further, IL-6 was highly correlated with insulin in women, but not in men.
In Oji-Cree women with either IGT or diabetes (Table 3) , in marked contrast to the above groups, there was a modest, nonsignificant correlation of CRP with BMI (P ¼ 0.0705), and no correlation with waist or WHR. Similar to normoglycemic women, CRP was significantly correlated with insulin. In contrast to normoglycemic women, CRP was not significantly correlated with FBG. In contrast to normoglycemic women, where CRP was positively correlated with age, CRP was modestly negatively correlated with age (P ¼ 0.02), but similar to normoglycemic women, CRP was negatively correlated with vitamin B 6 (Po0.0001). CRP, as expected, was strongly positively correlated with SAA and IL-6. SAA was not correlated with measures of obesity, or insulin, but was modestly negatively correlated with FBG (P ¼ 0.04). There was no correlation of SAA with age or vitamin B 6 . IL-6 was not correlated with measures of obesity or glycemia. However, there was a negative correlation between IL-6 and vitamin B 6 (P ¼ 0.0103).
In Oji-Cree men with either IGT or diabetes (Table 3) , there was significant correlation of CRP with all three measures of obesity, similar to the correlations observed for the Connelly C-reactive protein in the Sandy Lake Oji-Cree PW Connelly et al normoglycemic men. However, CRP was only significantly correlated with insulin (P ¼ 0.0231) and not correlated with FBG. In addition, CRP was not correlated with age, but was negatively correlated with vitamin B 6 (P ¼ 0.0035). Again, as expected, there was a strong positive correlation of CRP with SAA and IL-6. The correlation of SAA with measures of obesity and glycemia were not statistically significant in men, as in women, with either IGT or diabetes. There was no correlation of SAA with age in men with IGT or diabetes, and there was a nonsignificant negative correlation with vitamin B 6 . IL-6, in sharp contrast to men with normoglycemia, showed no statistically significant correlations with obesity measures. However, similar to normoglycemic men, there was no correlation of IL-6 with insulin, FBG or age, but there was a modest nonsignificant negative correlation with vitamin B 6 (P ¼ 0.075). Thus, IGT and diabetes appeared to disrupt most of the univariate correlations between the inflammatory factors CRP, SAA and IL-6, and the indices of obesity and glycemia in both men and women. Interestingly, several negative correlations with vitamin B 6 were present.
Serum CRP as a dichotomous trait
Since serum CRP concentration Z3.8 mg/l has been identified as a risk factor for myocardial infarction in men and women, 4 this level was used as a cut point for analysis of elevated CRP as a dichotomous qualitative trait. The numbers of women and men subdivided according to diabetes status with CRP Z3.8 oro3.8 mg/l are shown in Tables 4 and 5 , respectively. In all, 51% of women and 32% of men had elevated plasma CRP (Po0.0001). For women, the odds ratio for a general association between diabetes and elevated CRP was 3.35 (95% CI 2.05-5.5, Po0.0001). In all, 68.1% of women with diabetes or IGT had elevated CRP, compared to 38.8% of normoglycemic women. For men, the 
Determinants of serum CRP concentration
The determinants of serum CRP concentration were studied using the general linear models ANOVA with log CRP as the dependent variable and log IL-6, age, diabetes status (normoglycemic or affected with either IGT or diabetes) and log insulin as independent variables. Each model included either log waist, log BMI or log WHR as an independent variable to estimate the impact of obesity. The r 2 ranged from 0.32 to 0.40 for all models tested, for both women and men (data not shown). For both women and men, serum IL-6 was consistently a significant independent determinant of serum CRP. The impact of obesity varied depending upon the measure used. For women, both log waist and log BMI were strong significant independent determinants of CRP, whereas log WHR was not significant (data not shown). Regression analysis was carried out with either the combination of log BMI and log waist (Table 6 , model 1) or log BMI and log WHR (Table 6 , model 2). In both models, log BMI had the highest partial r 2 and neither waist circumference or WHR reached statistical significance. Diabetes status was of borderline significance in each model tested in women and insulin concentration was not significant. For men, statistical analysis using general linear models ANOVA identified all measures of obesity as significant independent predictors of CRP, whereas age was only significant in the model containing log BMI, and insulin was only significant in the model containing log WHR (data not shown). Regression analysis was carried out with either the combination of log BMI and log waist (Table 7 , model 1) or log BMI and log WHR (Table 7 , model 2). In contrast to the results for women, waist circumference (log waist) and WHR (log WHR) had the highest partial r 2 for CRP, while log BMI did not provide additional significance. Diabetes status did not reach statistical significance in any model. Insulin concentration was a significant factor in the model that included log WHR (Table 7 , model 2).
Discussion
The principal findings from this study of determinants of serum CRP in a North American aboriginal community with Abbreviations: as in Table 1 . Abbreviations: as in Table 1 . Abbreviations: as in Table 1 ; log, logarithm base 10. Abbreviations: as in Table 6 .
Connelly C-reactive protein in the Sandy Lake Oji-Cree PW Connelly et al a high prevalence of type II diabetes and high CHD risk were:
(1) the majority of Oji-Cree adults studied had elevated serum CRP, defined as concentration Z3.8 mg/l; (2) elevated serum CRP was more prevalent in Oji-Cree women than in men; (3) serum CRP was strongly correlated with inflammatory markers, indices of obesity, glycemia and insulinemia in nondiabetic Oji-Cree men and women; (4) serum CRP was strongly correlated with inflammatory markers, but less strongly correlated with indices of obesity, glycemia and insulinemia in men and women with diabetes or IGT; (5) elevated serum CRP was strongly associated with type II diabetes or IGT in both men and women; (6) serum IL-6 and indices of obesity were consistent determinants of serum CRP in both men and women in multivariate analyses; (7) plasma vitamin B 6 concentrations were negatively correlated with serum inflammatory markers in both men and women, both with and without diabetes. The findings indicate a high prevalence of elevated CRP in this adult Oji-Cree sample, suggesting that CHD risk, particularly among adult women, is higher than would be apparent from the measurement of traditional risk factors. The fact that a significant proportion of the variation in CRP is not explained by markers of obesity suggests that inclusion of both obesity and CRP will provide new, complementary information relevant to CHD risk. CRP, at levels below that characteristic of acute inflammation, is a newly recognized risk factor for atherosclerosis. [1] [2] [3] [4] [5] Elevated CRP results in a relative risk for CHD that is higher for women than for men. 2, 22 The adjustment for the risk factors, diabetes, smoking, BMI, blood pressure, cholesterol and HDL cholesterol, reduces the relative risk attributable to CRP to B2 for men 22 and B5 for women.
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The serum concentration of CRP has been reported to be positively associated with insulin resistance, 13 the cytokine IL-6 9,10 and obesity. 12 On the basis of the prevalence of obesity and diabetes in the Sandy Lake Oji-Cree, we postulated that there would be a high prevalence of elevated CRP, which this study confirmed. We also postulated that the elevation of CRP would be most closely associated with IL-6 and diabetes status or markers of diabetes status, and indeed, the odds ratio for a general association between diabetes and elevated CRP was B3 for both men and women in this study. Recent analyses from the Women's Health Study indicated that elevated levels of CRP and IL-6 predict the development of type II diabetes, supporting a possible causative role for inflammation in diabetogenesis. 23 However, our multivariate analyses indicated that CRP was most strongly associated with IL-6 and with markers of obesity. In contrast, diabetes status appeared to be less strongly associated with CRP concentration. In addition, the strength of association of obesity was dependent on gender and diabetes status. Festa et al 13 analyzed data from 1003 nondiabetic subjects, of whom 33% had IGT and 43% were men. Data were analyzed for the impact of ethnicity (non-Hispanic white, black, Hispanic), but not for gender differences. 27 It has been shown that CRP binds to pyridoxal phosphate with high affinity. 27 Thus it is possible that CRP has a physiologic role in modulating B 6 levels. The inverse relation between IL-6 and B 6 may be indirect through the effects on CRP. Furthermore, B 6 is a cofactor for a broad group of enzymes. No previous link has been made between vitamin B 6 requiring metabolic pathways and CRP. North American aboriginal populations have acquired an epidemic prevalence of type II diabetes and obesity. 16 Morbidity from CHD has been increasing in Canadian aboriginal populations. 18, 19 This study demonstrates that chronic inflammation, as reflected by elevated CRP, could be a major factor underlying the increase in CHD, independent of traditional risk factors. 19 The analysis of determinants of CRP has shown that obesity, IL-6, and vitamin B 6 can explain B30% of CRP variation, with obesity contributing some factor or factors independent of IL-6. Perhaps more important is the fact that up to 70% of CRP variation was not explained by the current analysis. It is tempting to speculate that aboriginal populations have, until about 50 years ago, have an excessive baseline innate immune surveillance, which after acquiring obesity is reflected in higher than expected levels of chronic inflammatory proteins, such as CRP. Alternatively, the possibility that the prevalence of elevated CRP is largely a result of the prevalence of obesity, with a minor contribution of genetic background, cannot be discounted on the basis of a cross-sectional, observational study design. The prospective study of this population and comparison with other genetically distinct populations will provide further insight into the relative contributions of these factors to the prevalence of elevated CRP. In addition, novel factors that might determine CRP levels, such as nonsteroidal products of HMG-CoA reductase, 3, 31 phospholipid oxidation 32 or genetic variation, 33 remain to be evaluated.
